Ravasio, R.; Viti, R.; Roscini, A. S. Cost Per Responder for Vedolizumab and Ustekinumab in Crohn’s Disease Patients After Failure of TNF-α Inhibitors in Italy. AboutOpen 2023, 10, 13-21.